<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech</h2>
    <div class="badge">2025-09-15T13:03:30+00:00</div>
    <ul>
      <li>Its competitive edge was the catalyst behind a 17% organic revenue growth in the second quarter of 2025 as earnings per share increased 23%.</li>
<li>The company has delivered a strong performance, with 21.44% revenue growth over the past 12 months.</li>
<li>In addition, the research firm has echoed the company’s projected 11%-13% compound annual growth rate outlook.</li>
<li>On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Perform and reiterated a $125 price target.</li>
<li>READ NEXT: 11 Best Wind Power and Solar Stocks to Buy According to Analysts and 10 Best Robinhood Penny Stocks to Invest In.</li>
<li>Disclosure: None.</li>
<li>This article is originally published at Insider Monkey.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Oppenheimer Touts Boston Scientific Corporation (BSX) as the Best Large-Cap MedTech\n• Its competitive edge was the catalyst behind a 17% organic revenue growth in the second quarter of 2025 as earnings per share increased 23%.\n• The company has delivered a strong performance, with 21.44% revenue growth over the past 12 months.\n• In addition, the research firm has echoed the company’s projected 11%-13% compound annual growth rate outlook.\n• On September 8, analysts at Oppenheimer upgraded the stock to an ‘Outperform’ from Perform and reiterated a $125 price target.\n• READ NEXT: 11 Best Wind Power and Solar Stocks to Buy According to Analysts and 10 Best Robinhood Penny Stocks to Invest In.\n• Disclosure: None.\n• This article is originally published at Insider Monkey." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/oppenheimer-touts-boston-scientific-corporation-130330776.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>